Institute

Aster Cancer Institute

Precision oncology across all solid and hematologic tumors.

120+

Active clinical trials

94%

5-year survival (breast, stage I,II)

14,200

Patients treated annually

Overview

Our Cancer Institute combines multidisciplinary tumor boards, molecular profiling for every new diagnosis, and more than 120 active clinical trials. Treatment plans are reviewed weekly by oncology, surgery, radiation, and pathology together.

Highlights

01Multidisciplinary tumor boards reviewing every new diagnosis
02In-house molecular profiling and biomarker testing
03120+ active clinical trials across solid and hematologic tumors
04NCI designation renewed in 2024

Programs

Breast Cancer ProgramLung Cancer ProgramGastrointestinal OncologyHematologic MalignanciesCellular Therapy (CAR-T)Survivorship Program

Led by

Dr. Priya Okafor, MD, PhD

Chief, Breast Oncology · Director, Cancer Institute

Appointment line

New patients seen within 5 business days.

Our patient navigation team triages every new request, verifies insurance, and matches you to the right specialist.